Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC

BACKGROUND: Adjuvant chemotherapy improves survival in patients with completely resected stage II and III NSCLC. However, its role in patients with stage IB NSCLC disease remains unclear. We evaluated the role of adjuvant chemotherapy in a large data set of patients with completely resected T2N0M0 N...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Thorac Oncol
Main Authors: Morgensztern, Daniel, Du, Lingling, Waqar, Saiama N., Patel, Aalok, Samson, Pamela, Devarakonda, Siddhartha, Gao, Feng, Robinson, Cliff G., Bradley, Jeffrey, Baggstrom, Maria, Masood, Ashiq, Govindan, Ramaswamy, Puri, Varun
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5141602/
https://ncbi.nlm.nih.gov/pubmed/27287414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.05.022
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares